PHVS: Pharvaris N.V. Company Short-Term Debt
Pharvaris N.V. (PHVS) relies on stable demand from patients with rare genetic edema who require lifelong therapy. The asset's price trajectory demonstrates the current indicator 0.00. The company is implementing innovative tablets for attack prevention to improve patients' quality of life. Scaling drug production is achieved through effective partnerships with external contractors, which minimizes manufacturing risks.
Metric breakdowns and analytics for Pharvaris Pharma (PHVS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Pharvaris N.V.|PHVS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Pharvaris N.V.|PHVS - Company Total Debt|Debt to Book Capitalization Ratio Pharvaris N.V.|PHVS - Company Long-Term Liabilities|Company Current Liabilities Pharvaris|Quick Liquidity pharvaris.com
- net income and valuation multiples indicators:
Initial company analysis:PHVS - Pharvaris
This indicator aggregates liabilities with maturities of up to one year, reflecting the liquid burden on the balance sheet from the financial statements. This metric measures the issuer's ability to avoid cash flow gaps and manage borrowing costs during periods of volatility. For Pharvaris N.V. (PHVS), debt control is critical when financing the development of an oral drug under the leadership of Lars Nibelbs. Optimizing liabilities secures resources for the future commercial launch. Analysis of this short-term debt segment confirms the financial stability of the management's strategy.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|Current Liabilities IMNM|GOSS: Company Short-Term Debts|kalvista.com - Company Short-Term Loans and Borrowings|SEPN (Septerna) - Company Short-Term Debts|Company Short-Term Debts Pieris Pharma|Company Short-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Short-Term Loans and Borrowings|AnaptysBio, Inc. - Company Current Liabilities|astriatx.com - Company Short-Term Debt|enGene - Company Short-Term Debts|RAPT - Company Short-Term Debts|aerovatetx.com (JBIO) - Company Short-Term Debt|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Short-Term Debt Cabaletta Bio (CABA)|Short-Term Debt Volume Ventyx Biosciences Inc.|Theratechnologies Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings AVTX|ELDN - Company Short-Term Debt|AGEN (agenusbio.com) - Company Short-Term Indebtedness|CLYM (Climb Bio) - Company Current Liabilities|ZURA - Short-Term Debt Volume|Company Current Liabilities ATYR|Company Short-Term Debt ADAG|Company Current Liabilities IMA (ImageneBio Inc)|Short-Term Debt Volume shattucklabs.com|Company Short-Term Debt Equillium EQ|CNTB (Connect Biopharma Holdings) - Current Liabilities|Immunic Inc - Company Short-Term Debts|Company Short-Term Loans and Borrowings ATRA (Atara Biotherapeutics)|IFRX (inflarx.de) - Company Current Liabilities|XFOR (x4pharma.com) - Company Short-Term Debt|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debt INmune Bio Corp (INMB)|BRNS: Current Liabilities|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Loans and Borrowings SABS|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|q32bio.com (QTTB) - Company Short-Term Debt|GeoVax Corp - Company Short-Term Loans and Borrowings|Company Short-Term Debt Edesa Biotech, Inc.|Company Current Liabilities ibioinc.com (IBIO)|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Bolt Biotherapeutics, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|Short-Term Debt Volume aimimmuno.com AIM|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Current Liabilities REVB (Revelation Biosciences)|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI: Company Short-Term Indebtedness|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Allakos Inc.|hookipapharma.com (HOOK) - Company Short-Term Debt|Current Liabilities IGMS (IGM Biosciences)|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc (THRD)